- Home
- CDTX vs KFS Comparison
CDTX vs KFS Comparison
Compare CDTX & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- KFS
- Stock Information
- Founded
- CDTX 2012
- KFS 1989
- Country
- CDTX United States
- KFS United States
- Employees
- CDTX N/A
- KFS N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- KFS Property-Casualty Insurers
- Sector
- CDTX Health Care
- KFS Finance
- Exchange
- CDTX Nasdaq
- KFS Nasdaq
- Market Cap
- CDTX 259.0M
- KFS 220.3M
- IPO Year
- CDTX 2015
- KFS 1996
- Fundamental
- Price
- CDTX $17.82
- KFS $7.72
- Analyst Decision
- CDTX Strong Buy
- KFS
- Analyst Count
- CDTX 8
- KFS 0
- Target Price
- CDTX $38.00
- KFS N/A
- AVG Volume (30 Days)
- CDTX 156.0K
- KFS 104.2K
- Earning Date
- CDTX 05-14-2025
- KFS 05-07-2025
- Dividend Yield
- CDTX N/A
- KFS N/A
- EPS Growth
- CDTX N/A
- KFS N/A
- EPS
- CDTX N/A
- KFS N/A
- Revenue
- CDTX $1,275,000.00
- KFS $112,710,000.00
- Revenue This Year
- CDTX N/A
- KFS N/A
- Revenue Next Year
- CDTX N/A
- KFS N/A
- P/E Ratio
- CDTX N/A
- KFS N/A
- Revenue Growth
- CDTX N/A
- KFS 3.29
- 52 Week Low
- CDTX $10.00
- KFS $7.06
- 52 Week High
- CDTX $28.42
- KFS $9.58
- Technical
- Relative Strength Index (RSI)
- CDTX 33.85
- KFS 47.79
- Support Level
- CDTX $19.83
- KFS $7.68
- Resistance Level
- CDTX $23.76
- KFS $8.24
- Average True Range (ATR)
- CDTX 1.58
- KFS 0.31
- MACD
- CDTX -0.53
- KFS 0.03
- Stochastic Oscillator
- CDTX 5.11
- KFS 47.47
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.